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ABSTRACT The MADS domain homeotic proteins
APETALA1 (API), APETALA3 (AP3), PISTILLATA (PI),
and AGAMOUS (AG) act in a combinatorial manner to
specify the identity ofArabidopsis floral organs. The molecular
basis for this combinatorial mode of action was investigated.
Immunoprecipitation experiments indicate that all four pro-
teins are capable of interacting with each other. However,
these proteins exhibit "partner-specificity" for the formation of
DNA-binding dimers; only AP1 homodimers, AG homodimers,
and AP3/PI heterodimers are capable ofbinding to CArG-box
sequences. Both the AP3/PI heterodimer and the API or AG
homodimers are formed when the three corresponding pro-
teins are present together. The use of chimeric proteins
formed by domain swapping indicates that the L region (which
follows the MADS box) constitutes a key molecular determi-
nant for the selective formation of DNA-binding dimers. The
implications of these results for the ABC genetic model of
flower development are discussed.
The study of homeotic mutants in Arabidopsis thaliana and
Antirrhinum majus has led to the establishment of a genetic
model (the ABC model) that explains how the fates of floral
organ primordia are determined (1, 2). According to the ABC
model, the identities of the organs of an Arabidopsis flower
(four sepals, four petals, six stamens, and two carpels) are
specified by the action of at least five organ identity genes, all
of which have been cloned: APETALA1 (AP1), APETALA2
(AP2),APETALA3 (AP3), PISTILLATA (PI), andAGAMOUS
(AG) (3-7). In situ hybridization and ectopic expression ex-
periments (8-10) have provided strong evidence supporting
the ABC model, showing that each whorl of a flower primor-
dium has a unique combination of organ identity activities,
which combinatorially specify organ identity. The specification
of sepals is dependent on class A gene activities (AP1 and
AP2), petals are specified by a combination of class A and class
B (AP3 and PI) gene activities, stamens are specified by the
combined activities of classes B and C (AG), and specification
of the carpels is achieved by class C activity.
AP1, AP3, PI, and AG are all MADS domain-containing
proteins (Fig. 1), while AP2 bears similarity to a different class
of DNA binding proteins (4, 13). The MADS domain is a
conserved region of 56 amino acids present in a variety of
dimeric transcription factors from different organisms. The
MADS regions of SRF and MCM1 have been characterized as
DNA binding and dimerization domains (11, 14). Within the
family of MADS box proteins, the plant proteins are unique in
that they contain another conserved region, the K box, that
may form amphipathic alpha helices (ref. 12; Fig. 1). SRF and
MCM1 bind to CArG-box sequences [consensus CC(A/
T)6GG] (11, 15, 16), and it has been shown that AG binds to
such sequences (17-19). The Antirrhinum DEFICIENS (DEF,
the ortholog ofAP3) and GLOBOSA (GLO, the ortholog of
P1) proteins have been shown to bind together as a hetero-
complex, providing a molecular mechanism to explain the
requirement for both genes in the B function (20, 21).
While APl, AP3, PI, andAG have been extensively charac-
terized at the genetic level, little is known about the molecular
mechanisms by which their protein products act. One possible
mechanism by which AP1, AP3, and PI (which specify petals)
and AP3, PI, and AG (which specify stamens) could act
combinatorially to dictate a developmental program is through
heterocomplex formation. Can the four proteins interact with
each other? If they interact, are all the different homo- and
heterocomplexes capable of binding to DNA? If this is not the
case, and the proteins present partner-specificity for the
formation of DNA-binding complexes, where in the proteins
are the determinants for this partner-specificity localized?
Here, we show that AP1, AP3, PI, and AG are all capable of
interacting with each other, but that only AP1/AP1, AP3/PI,
and AG/AG dimers (and also heterodimers formed by trun-
cated AG and AP1) bind to CArG-box containing sequences.
This DNA-binding partner specificity is mediated to a large
degree by the L region of these proteins, a 31-35 aa segment
located between the MADS and K boxes.
MATERIALS AND METHODS
Plasmid Constructioh. AP1, AP3, PI, andAG cDNA coding
sequences were cloned into the pSPUTK in vitro translation
vector (Stratagene). Because the initiatingATG codon was not
found in the AG cDNA clones (7), the wild-type sequence
5'-CATTTT ... at the beginning oftheAG cDNAwas changed
to 5'-ATGGGG.... The in vivo functionality of such an altered
AG protein has been shown in ectopic expression experiments
(8). The construction of PPIFLAG, to make FLAG epitope-
tagged PI protein, has been previously described (ref. 6; the
sequence KDDDADYKDDDDK was added at the C terminus
of the protein). Similar constructs were made for AP1, AP3,
and AG. A derivative ofAG,AGNML (to produce a C-terminal
truncated protein that comprises the N-terminal amino acids
that precede the AG MADS box, and the MADS domain and
L region), was synthesized by PCR and cloned into pSPUTK.
C-terminal deletion derivatives of AP1, AP3, and PI
(AP1M+33, AP3ML+31, and PIML+20, respectively) were ob-
tained by digesting the plasmids encoding the full-length
proteins with internal restriction sites (BsrI,AlwNI, and BpmI,
respectively) before the in vitro transcription reaction. Chi-
meric constructs were made by synthesizing and fusing cDNA
fragments by PCR techniques so that no amino acids (others
than those of the domains that were swapped) were changed
in the resulting chimeras. Sequences were fused at the end of
the MADS box and at the end of the L region (Fig. 1) of the
Abbreviations: AP1, APETALA1; AP2, APETALA2; AP3,
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FIG. 1. Alignment of the amino acid sequences ofAG, AP1, AP3, and PI. Beneath them are shown the sequences of core serum response factor
(SRF) and MCM1. The MADS and K boxes and the N, L, and C regions are indicated; amino acids identical among AG, AP1, AP3, and PI are
shaded. Relevant features of the MADS box are indicated; amino acids identical among all the proteins belonging to the MADS box family are
noted with filled circles, and those that are highly conserved (S/T, Y/F, L/I, R/K) with open ones. SRF residues that have been found to be involved
in DNA binding (-) and dimerization (-) are indicated (11). aI, I3I, ,311, and aII indicate secondary structure elements observed in the crystal
structure of SRF (11). Two possible helices in the K box are indicated (12), with residues at positions a and d in the coiled coil heptapeptide repeat
marked.
corresponding genes, AG, AP3, and PI. The initiation codon
for those chimeras that included AG N-terminal sequences was
engineered in an NcoI context at amino acid residue 34 of
wild-typeAG cDNA (7, 8). The chimeric constructs were cloned
into pSPUTK
DNA-Binding Site Probes. Probes A and B are derived from
the promoters of the Arabidopsis AP3 (22) and SUPERMAN
(H. Sakai, L. Medrano, and E.M.M., unpublished data) genes,
respectively. Probe A: 5'-ggatccTCACTTAGTTTTCATCA-
ACTTCTGAACTTACCTTTCATGGATTAGGCAATA-
CTTTCCATTTTTAGTAACTaagctt-3'; probe B: 5'-ggatcc-
TAAGAAAAATGGGAGAAAGGAACATCCACTTTTC
CATTTTTGGTATAAAACTTTTGATATAATATGTCCT-
TTTGCTaagctt-3'; (the CArG-boxes are underlined and the
plasmid-derived linker sequences are in lowercase type). Bind-
ing probes were labeled with 32P by Klenow fill-in reaction and
were purified by PAGE before their use in DNA-binding
experiments.
Immunoprecipitation and DNA-Binding Assays. Proteins
were synthesized using the TNT reticulocyte lysate system
(Promega) or in separate transcription and translation reac-
tions. Labeled [35S]methionine in vitro translation reactions
demonstrated that the proteins were produced in similar
amounts. AP1, AP3, PI, and AG were synthesized as both
epitope-tagged unlabeled and native [35S]methionine-labeled
proteins for the immunoprecipitation experiments, which were
performed as described (6) with slight modifications. In brief,
the in vitro translation solution was diluted with an equal
volume of 2x buffer A (6). The diluted protein solutions
(10-30 ,ul) were mixed and incubated at room temperature for
30-45 min to allow protein association. Ice-cold buffer B (400
,ul) (6) and 1.5 ,tg of anti-FLAG M2 monoclonal antibody
(Kodak-IBI) were added and the samples were incubated at
4°C on a rotating wheel for 30 min. Protein A-Sepharose CL4B
slurry (100 ,lA; Sigma, equilibrated in buffer A) was then added
and the incubation continued for 1 hr. The sepharose beads
were collected by centrifugation and washed 4x with RIPA
buffer (50 mM Tris-HCl, pH 8/150 mM NaCl/1% deoxy-
cholate/1% Triton X-100/0.2% SDS/4 mg/ml BSA), once
with LiCl/urea buffer (10 mM Tris-HCl pH 8/400 mM LiCl/2
M urea), and once with water. Immunoprecipitated proteins
were analyzed by SDS/PAGE on 12.5% gels. In vitro translated
proteins were tested for DNA-binding activity by electro-
phoretic mobility-shift assay. The standard binding reaction
(final vol of 10 ,ul) contained 2 ,ul of the translation mixture,
20 mM Tris HCl (pH 8), 100 mM KCl, 1 mM EDTA, 1 mM
dithiothreitol, 12% glycerol, 2.5 ,tg of BSA, 200 ng of double-
stranded poly(dIdC) (Pharmacia), and 200 ng of sonicated calf
thymus DNA (Pharmacia). Reactions were preincubated at
room temperature for 25 min and for a further 15 min after the
addition of the labeled probe (10,000-20,000 cpm; final con-
centration of 0.12-0.25 nM). Gels for resolving protein-DNA
complexes were 5% polyacrylamide/bisacrylamide (60:1) in 1
x TBE.
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RESULTS
Interactions of AP1, AP3, PI, and AG. The ability of these
four proteins to interact with each other was investigated by
immunoprecipitation. Epitope-tagged AP1, AP3, PI, or AG
was mixed with nontagged, radioactively labeled proteins and
coprecipitated using the tag antibody. This assay has been used
previously to show that AP3 and PI proteins associate in
solution (6). Coprecipitation of each labeled protein was
observed with all of the tagged proteins (Fig. 2). Labeled AP1
was precipitated by tagged AP1, AP3, PI, and AG at levels well
above the background (Fig. 2, lanes 1-5), and similar results
were obtained for labeled AP3, PI, and AG (Fig. 2). These
results indicate that AP1, AP3, PI, and AG can interact with
each other in vitro.
DNA-Binding Activity of API, AP3, PI, and AG. The ability
of these various complexes to bind DNA was investigated.
Proteins were synthesized by cotranslation in different com-
binations and analyzed with probe A by electrophoretic mo-
bility-shift assays, in which the different MADS box protein-
DNA complexes are distinguishable by their different mobil-
ities. As expected, the DNA-binding complexes formed by
these proteins are dimers (J.L.R. and E.M.M., unpublished
results). AP1, AP3/PI, and AG dimers showed DNA-binding
activity (Fig.3A, lanes 2,5, and 8). AP3 and PI homocomplexes
did not bind to probe A (Fig. 3A, lanes 6 and 7). When either
of these two proteins was present in combination with AG, the
only band shifts detected were those due to the AG protein
alone (Fig.3A, lanes 8-10). Similarly, AP1/AP3 and APi/PT
reactions only showed the bands corresponding to AP1 (Fig.
3A, lanes 2-4). The same results were obtained using probe B
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FIG. 2. AP1, AP3, PI, and AG can interact with each other.
[35S]-methionine-labeled in vitro translated proteins (5,l) were mixed
with in vitro translated epitope-tagged AP1 (11,lI), AP3 (15 Al), PI (10
,lI), or AG (10 plA), or with unprogrammed lysate (as control for
nonspecific precipitation), and subjected to immunoprecipitation with
an anti-FLAG monoclonal antibody. The number of methionines in
these proteins is AP1, 11; AP3, 4; PI, 13; AG, 6. Lanes 6-10 show a
longer exposure of the autoradiogram than the other lanes. The failure
to detect coprecipitation of labeled AP3 with tagged AP1 in this
experiment (lane 6) resulted from both the weakness of the AP1-AP3
interaction and a presumably low amount of tagged AP1 produced in
the translation reaction (this particular coprecipitation was observed
in other experiments; not shown). A quantitative comparison of all
these interactions is partially precluded, because the amount of each
of the tagged proteins may be different and because several reactions
(which might not be at equilibrium) coexist in each assay while only
one of them is detected. The band with higher mobility in lanes 1-4
corresponds to a truncated AP1 protein that is produced in the
translation reaction.
and with additional CArG-box containing probes, or when the
proteins were translated separately and mixed afterwards
(data not shown). Although AP1, AP3, PI, and AG can
interact with each other, these data indicate that the ability to
form DNA-binding complexes that recognize the binding sites
used is restricted to certain combinations (AP1, AP3/PI, and
AG). The interaction between AG and AP1 could not be
assayed with the two full-length proteins, because both pro-
teins produce band shifts at similar positions that, in addition,
are very different in their intensities. When truncated forms of
AG and AP1 were assayed together, a band corresponding to
a heterodimer between these two proteins was detected (data
not shown). This AP1/AG interaction is probably irrelevant (if
existent) in vivo, because AG and AP1 are not active in the
same cells (3, 7, 23, 24).
Two different protein-DNA complexes were detected when
either AP1, AP3, and PI, or AP3, PI, and AG were synthesized
by cotranslation and analyzed in electrophoretic mobility-shift
assays. The presence of AP1, AP3, and PI together resulted in
band shifts corresponding to AP1 homodimers and AP3/PI
heterodimers (Fig. 3B). Similarly, when cotranslated AP3, PI,
and AG were incubated with DNA, simultaneous DNA bind-
ing by AP3/PI and AG dimers was detected (Fig. 3C). Thus,
different DNA-binding MADS box protein complexes can
coexist, at least within a certain range of relative protein
concentrations. These data suggest that DNA-binding AP1
homodimers and AP3/PI heterodimers are formed in primor-
dial petal cells that express AP1, AP3, and PI, and that
DNA-binding AG homodimers and AP3/PI heterodimers
form in primordial stamen cells that express AG, AP3, and PI.
Localization of Dimerization-Specificity Determinants. C-
terminal deletion analysis of AP1, AP3, PI, and AG indicated
that the "core" portion (minimal DNA-binding domain) of
AP1 and AG includes the MADS box and part of the L region,
whereas AP3 and PI require the first amino acids of the K box,
in addition to the MADS domain and L region, to form a
DNA-binding complex (J.L.R. and E.M.M., unpublished re-
sults). When the "core" proteins were assayed for DNA
binding activity in different combinations, it was found that the
partner-specificity observed in the full-length proteins is pre-
served in the "core" derivatives: AP3ML+31 (truncated protein
that contains the MADS box, L region, and the first 31 amino
acids of the K box) and PIML+20 do not form DNA-binding
homodimers (data not shown), consistent with the fact that
neither AP3 nor PI have such activity (Fig. 3). Reactions that
included either AGNML or AP1M+33 (which contains 33 amino
acids of the 35-aa long L region) and AP3 or PI truncated
proteins only showed the bands corresponding to DNA binding
by the AGNML and AP1M+33 homodimers (data not shown).
To localize the protein region(s) responsible for partner-
specificity, chimeric proteins formed by domain swapping
between AG, AP3, and PI were used in DNA-binding exper-
iments. BGFN1 hybrid protein contains N-terminal sequences
from AG (part of the N-terminal region and the MADS box)
fused to the AP3 L, K, and C regions (Fig. 4B). BGFN1 bound
DNA as a heterodimer with PI, but not with AP1, AP3, or AG
(Fig. 4A, lanes 2-5). In addition, BGFN1 did not bind to DNA
as a homodimer (Fig. 4A, lane 1). This result indicates that the
determinants for the specificity of the interaction between
AP3 and PI reside C terminal to the MADS domain. BGFN2
differs from BGFN1 in that its L region is from AG instead of
AP3 (Fig. 4B). In contrast with BGFN1, BGFN2 bound DNA
as a homodimer and did not interact with PI in a productive
(DNA-binding) fashion (Fig. 4A, lanes 6-10). The results
obtained with BGFN1 and BGFN2 therefore indicate that the
L region is a key determinant for formation of partner-specific
DNA-binding complexes.
BGFN5 contains the AP3 MADS domain and L region
fused to the AG K box and C region (Fig. 4B). BGFN5 did not
exhibit DNA-binding activity either as a homodimer or in any
Plant Biology: Riechmann et al.
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FIG. 3. AP1, AP3, PI, and AG show partner specificity for the formation of DNA-binding complexes. (A) Proteins were synthesized by in vitro
transcription/translation in the indicated combinations and assayed with probe A. The various shifted bands present in the reactions with AP1 and
AG correspond to protein-DNA complexes formed by the full-length proteins as well as by truncated proteins also produced in the translation
reactions. The intensities of shifted bands corresponding to AP1 and AG complexes are reduced when AP3 or PI are present (lanes 2-4 and 8-10),
an effect that could be due both to differences in the amount of protein produced when cotranslated and to titration of some of the AP1 and AG
proteins away from DNA-binding homodimers. A control with unprogrammed lysate is included (lane 1). (B) AP1 and AP3/PI DNA-binding
complexes can coexist. In vitro cotranslated proteins were tested for DNA-binding with probe B. Three different cotranslations of AP1, AP3, and
PI, varying in the amounts of plasmids used, were assayed (lanes 4-6; the relative amounts of AP1/AP3/PI-producing plasmids in each translation
reaction were 0.7/1/0.5, 1.4/1/0.3, and 1/1/0.2). Positions of the shifts originated by AP1 full-length homodimers and AP3/PI heterodimers are
indicated by arrows. The strong reduction of AP1 DNA-binding activity (but not of AP3/PI) when the three proteins are cotranslated likely arises
from differences in the strength of the interactions among them. Immunoprecipitation experiments indicated that the AP3/PI interaction is stronger
than the AP1/PI, and the latter stronger than that ofAPI/AP1 (data not shown). (C) AG and AP3/PI DNA-binding complexes can coexist. Three
different cotranslations of AG, AP3, and PI were assayed with probe B (lanes 4-6; the relative amounts of AG/AP3/PI-producing plasmids in
each translation reaction were 1.2/1/0.4, 1.7/1/0.4, and 2.3/1/0.4). Positions of the shifts originated by AG full-length homodimers and AP3/PI
heterodimers are indicated by arrows.
combination (Fig. 4A, lanes 11-15). The inability of this
protein to form a DNA-binding complex with PI is consistent
with the defined cores of AP3 and PI, which require the first
amino acids of the K box to form a DNA-binding heterodimer
(see above), and indicates that this part of the AG protein
cannot substitute for the corresponding region in AP3. Thus,
in the case of AP3, determinants for partner-specificity, al-
though centered in the L region, extend C terminal to it.
BGFN7 contains N-terminal sequences from AG (part of
the N terminal region and the MADS box) fused to the PI L,
K, and C regions (Fig. 4B). Consistent with the role ascribed
to the L region, BGFN7 bound DNA as a heterodimer with
AP3 (Fig. 4A, lane 18). It was also capable of forming a
DNA-binding homodimer (Fig. 4A, lane 16) and showed a
weak DNA-binding interaction with a truncated AG protein,
AGNML (Fig. 4A, lanes 21 and 22). The ability of BGFN7 to
form a heterodimer with full-length AG could not be deter-
mined as the BGFN7 and AG homodimers produce similarly
shifted bands. These results indicate that (i) the PI L, K, and
C regions differ from the corresponding domains ofAP3 since
they can form a homodimer when fused to an AG MADS box,
while those of AP3 cannot (Fig. 4A, lane 1) and (ii) although
theAG MADS box could substitute for the PI one, they are not
equivalent since the AG MADS box conferred a new capability
to the chimeric protein, that of forming homodimers. Differ-
ences between the AG MADS box and the PI MADS box were
also indicated by chimeric protein BGFN9, in which a PI
MADS box is fused to AG L, K, and C regions (Fig. 4B).
BGFN9 was unable to bind to DNA, either alone or in
combination with AP1, AP3, PI, AG, or AGNML (Fig. 4A,
lanes 23-27). The inability of BGFN9 to form a DNA-binding
homodimer or a heterodimer with AG indicates that the AG
MADS box (likely its C-terminal half) plays a role in partner
specificity. In summary, the results from the experiments with
these chimeric proteins indicate that the determinants for
partner-specificity are centered in the L region, but also
include sequences C terminal to it (for the AP3/PI het-
erodimer) or N terminal to it (for the AG homodimer).
DISCUSSION
The results indicate that although AP1, AP3, PI, and AG can
interact in solution, they exhibit partner-specificity for the
formation of DNA-binding dimers. In addition, they provide
evidence for the critical involvement of amino acids C terminal
to the MADS box in determining the DNA-binding dimeriza-
tion selectivity of the MADS domain proteins. This function of
the L region is consistent with it being a segment that varies
considerably, both in sequence and length (27-42 amino
acids), within the plant MADS box family of proteins (25, 26).
The involvement of the region C terminal to the MADS box
in dimerization selectivity was also suggested from experi-
ments that showed that SRF, MCM1, and ARG80, which share
loose sequence similarity in this region, can dimerize with each
other in vitro (17, 27), whereas SRF cannot dimerize with
MEF2 proteins (28) with which it does not share such similarity
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FIG. 4. DNA-binding activity of AP3-AG and PI-AG hybrid proteins. (A) Chimeric proteins BGFN1 (lanes 1-5), BGFN2 (lanes 6-10), BGFN5
(lanes 11-15), BGFN7 (lanes 16-22), and BGFN9 (lanes 23-27) were synthesized by in vitro translation and assayed for DNA-binding activity by
themselves or in combination with AP1, AP3, PI, AG, and AGNML (a truncated AG protein comprising the N terminal region, and the MADS
box and L region) using probe A. In lanes 2, 7, 12, 17, and 24, the band corresponding to an AP1 homodimer is seen. The band corresponding
to the AG homodimer in lanes 5, 15, and 27 required a longer exposure of the autoradiograms to appear. (B) Structure of MADS domain chimeric
proteins and summary of the results obtained in the DNA-binding experiments. The question mark and the asterisk assigned to the combination
of BGFN7 and AG proteins indicate that such a heterodimer could not have been detected in the experiment, but that a weak interaction between
BGFN7 and AGNML was observed.
(14). The recently determined crystal structure of core SRF
bound to DNA showed that some of the contacts between the
two monomers involve amino acids in this part of the protein
(11). The differences in the size of the core proteins and in the
regions involved in partner specificity indicate that the dimer-
ization requirements of AP3 and PI are different from those
of AG and AP1, perhaps explaining the apparent inability of
heterodimers between AP3 or PI and AG or AP1 to bind
DNA.
The partner-specificity that AP1, AP3, PI, and AG exhibit
has implications for the translation of the ABC genetic model
of flower development into a molecular mechanism. At least
two different scenarios can be envisioned to account for the
combinatorial mode of action of AP1, AP3, PI, and AG. One
possibility is that there may be direct interactions between
these proteins, therefore forming new complexes with addi-
tional regulatory capabilities. Another possible mechanism is
that these proteins do not interact directly and it is the various
combinations of downstream genes activated or repressed by
the AP1, AP3/P1, and AG complexes that determine the
identity of an organ. The genetic data that have been obtained
during the past years do not allow the validation or rejection
of either scenario. The results presented here do not support
a functional role for complexes like PI/AG, because AP3 and
PI homodimers and AP3/AG, PI/AG, AP3/AP1, and PI/
AP1 heterodimers are apparently unable to bind DNA. The
results obtained with the chimeric proteins indicate that the
inability of certain combinations of AP1, AP3, PI, and AG
proteins to form DNA-binding dimers does not arise from
different DNA sequence specificities of the MADS boxes. This
is exemplified by BGFN1, which showed that a dimer contain-
ing an AG MADS box and a PI MADS box recognizes probe
A, in contrast with the inability of the AG/PI complex to bind
to such a probe. Similarly, a dimer containing an AG MADS
box and an AP3 MADS box (BGFN7/AP3) binds to DNA,
whereas the AG/AP3 complex does not. Additional possibil-
ities that cannot be excluded on the basis of the in vitro
experiments are that the protein complexes have a cellular
function in the absence of DNA-binding activity, or that these
complexes are capable of DNA-binding in the presence of
additional proteins. However, in vivo data support the idea that
at least some of the non-DNA-binding complexes are non-
functional. It has been shown that PI is necessary for the
accumulation ofAP3 protein (9). An explanation for this result
is that AP3 might be stable in the cell onlywhen it is complexed
with PI, implying that PI is the only AP3 partner among the
four proteins we have studied. The possible dimerization
partners for AP1, AP3, PI, and AG are not restricted to these
four proteins, however, since the plant MADS box family of
proteins is quite large, with over 20 members already identified
inArabidopsis, many ofwhich are expressed in flowers (12, 25).
Nevertheless, it should be kept in mind that the extensive
genetic analyses have so far identified only these four proteins
as the products of homeotic genes controlling floral organ
identity. In summary, the results obtained with AP1, AP3, PI,
and AG do not lend support to the idea that the combinatorial
mode of action of the A (AP1), B (AP3 and PI), and C (AG)
gene activities during flower development is achieved through
hi
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direct interactions between the corresponding proteins and the
concomitant formation of new DNA-binding complexes with
novel regulatory capabilities. Rather, the number of different
DNA-binding complexes that AP1, AP3, PI, and AG can form
appears to be limited by the partner-specificity that these
proteins exhibit.
We are grateful to Xuemei Chen, Jennifer Fletcher, Jian Hua, Steve
Jacobsen, Joshua Levin, Zhongchi Liu, and Hajime Sakai for com-
ments on the manuscript, and to Carl Parker for valuable discussions
and suggestions. This work was supported by National Science Foun-
dation Grant MCB-9204839 (E.M.M.). J.L.R. was a recipient of an
European Molecular Biology Organization postdoctoral fellowship
and is now supported by a fellowship from Ministerio de Educaci6n y
Ciencia (Spain). B.A.K. was supported by American Cancer Society
postdoctoral fellowship PF-3911.
1. Coen, E. S. & Meyerowitz, E. M. (1991) Nature (London) 353,
31-37.
2. Weigel, D. & Meyerowitz, E. M. (1994) Cell 78, 203-209.
3. Mandel, M. A., Gustafson-Brown, C., Savidge, B. & Yanofsky,
M. F. (1992) Nature (London) 360, 273-277.
4. Jofuku, K. D., den Boer, B. G. W., van Montagu, M. & Okamuro,
J. K. (1994) Plant Cell 6, 1211-1225.
5. Jack, T., Brockman, L. L. & Meyerowitz, E. M. (1992) Cell 68,
683-697.
6. Goto, K. & Meyerowitz, E. M. (1994) Genes Dev. 8, 1548-1560.
7. Yanofsky, M. F., Ma, H., Bowman, J. L., Drews, G. N., Feld-
mann, K. A. & Meyerowitz, E. M. (1990) Nature (London) 346,
35-39.
8. Mizukami, Y. & Ma, H. (1992) Cell 71, 119-131.
9. Jack, T., Fox, G. L. & Meyerowitz, E. M. (1994) Cell 76,703-716.
10. Krizek, B. A. & Meyerowitz, E. M. (1996) Development (Cam-
bridge, U.K) 122, 11-22.
11. Pellegrini, L., Tan, S. & Richmond, T. J. (1995) Nature (London)
376, 490-498.
12. Ma, H., Yanofsky, M. F. & Meyerowitz, E. M. (1991) Genes Dev.
5, 484-495.
13. Weigel, D. (1995) Plant Cell 7, 388-389.
14. Shore, P. & Sharrocks, A. D. (1995) Eur. J. Biochem. 229, 1-13.
15. Pollock, R. & Treisman, R. (1990) Nucleic Acids Res. 18, 6197-
6204.
16. Wynne, J. & Treisman, R. (1992) Nucleic Acids Res. 20, 3297-
3303.
17. Mueller, C. G. F. & Nordheim, A. (1991) EMBO J. 10, 4219-
4229.
18. Huang, H., Mizukami, Y., Hu, Y. & Ma, H. (1993) Nucleic Acids
Res. 21, 4769-4776.
19. Shiraishi, H., Okada, K. & Shimura, Y. (1993) PlantJ. 4,385-398.
20. Schwarz-Sommer, Z., Hue, I., Huijser, P., Flor, P. J., Hansen, R.,
Tetens, F., Lonnig, W.-E., Saedler, H. & Sommer, H. (1992)
EMBO J. 11, 251-263.
21. Trobner, W., Ramirez, L., Motte, P., Hue, I., Huijser, P., Lonnig,
W.-E, Saedler, H., Sommer, H. & Schwarz-Sommer, Z. (1992)
EMBO J. 11, 4693-4704.
22. Okamoto, H., Yano, A., Shiraishi, H., Okada, K. & Shimura, Y.
(1994) Plant Mol. Biol. 26, 465-472.
23. Bowman, J. L., Alvarez, J., Weigel, D., Meyerowitz, E. M. &
Smyth, D. R. (1993) Development (Cambridge, U.K) 119, 721-
743.
24. Gustafson-Brown, C., Savidge, B. & Yanofsky, M. (1994) Cell 76,
131-143.
25. Rounsley, S. D., Ditta, G. S. & Yanofsky, M. F. (1995) Plant Cell
7, 1259-1269.
26. Purugganan, M. D., Rounsley, S. D., Schmidt, R. J. & Yanofsky,
M. F. (1995) Genetics 140, 345-356.
27. Sharrocks, A. D., Gille, H. & Shaw, P. (1993) Mo. Cell Biol. 13,
123-132.
28. Pollock, R. & Treisman, R. (1991) Genes Dev. 5, 2327-2341.
Proc. Natl. Acad. Sci. USA 93 (1996)
